Paul Well

104 statements · 4 topics

Featured statements

▶ Ep 5 · 1:17
So, a term baby uh will have 160 centimeters of small bowel, and by the time you're 5 years old, it, it almost triples, about 425 to 450 centimeters.
quote · Cholestasis
▶ Ep 5 · 1:51
But you can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity.
quote · Cholestasis
▶ Ep 7 · 6:50
Breast milk, not only for its nutritional uh benefits, obviously, but, uh, all the other goodies that are within the breast milk.
quote · Cholestasis
▶ Ep 7 · 8:15
Long chain fat is a much stronger stimulus for GLP-2 release, and that's what we want when we're trying to drive adaptation.
quote · Cholestasis
▶ Ep 25 · 8:07
But I would argue that uh long chain fat is the preferred module rather than MCT.
▶ Ep 25 · 6:15
If the child fails a gastric approach (both bolus and continuous), the strategy is to feed beyond the stomach and decompress the stomach through an NG tube.
clinical · Intestinal Failure

Nothing matches these filters — clear the search or widen the filters.

Paul's statements about Cholestasis 26 statements

Open the Cholestasis collection →

Intestinal Rehabilitation Webinar 2023 - Top 5 Key Takeaways

▶ Ep 5 · 0:49
clinical Young infants, babies, and young children have tremendous gut growth potential, with the gut growing for the first several years of life. ↗
▶ Ep 5 · 0:49
quote One key thing to, to acknowledge is that young infants, babies, infants, and young children have tremendous gut growth potential. ↗
▶ Ep 5 · 0:58
quote The gut grows for the first several years of life. ↗
▶ Ep 5 · 1:02
clinical Residual bowel should be discussed as a percentage of what is normal for a child of that age, not in absolute centimeters. ↗
▶ Ep 5 · 1:17
clinical A term baby will have 160 centimeters of small bowel, and by age 5 years it almost triples to about 425 to 450 centimeters. ↗
▶ Ep 5 · 1:17
quote So, a term baby uh will have 160 centimeters of small bowel, and by the time you're 5 years old, it, it almost triples, about 425 to 450 centimeters. ↗
▶ Ep 5 · 1:51
quote But you can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 5 · 1:51
clinical You can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 5 · 5:08
quote The overarching principle is we want to, we want to deliver adequate nutrition to, to have normal growth. ↗
▶ Ep 5 · 5:08
clinical The overarching principle is to deliver adequate nutrition to have normal growth within normal parameters, ideally enterally. ↗
▶ Ep 5 · 5:28
clinical As much as possible, the goal is to establish normal feeding behavior, recognizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 5 · 5:28
quote The other guiding principle is, as much as possible, we'd like to try to establish normal feeding behavior. ↗
▶ Ep 5 · 5:34
quote Realizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 5 · 5:52
clinical If a patient needs tube support from the beginning, bolus feeding should be tried rather than defaulting to continuous feeding. ↗
▶ Ep 5 · 6:15
clinical If the child fails a gastric approach (both bolus and continuous), the strategy is to feed beyond the stomach and decompress the stomach through an NG tube. ↗
▶ Ep 5 · 6:42
clinical Breast milk is the formula of choice, not only for its nutritional benefits but for all the other beneficial components within breast milk. ↗
▶ Ep 5 · 6:50
quote Breast milk, not only for its nutritional uh benefits, obviously, but, uh, all the other goodies that are within the breast milk. ↗
▶ Ep 5 · 7:25
quote So let's talk about the protein module first. ↗
▶ Ep 5 · 7:57
quote There's this feeling out there that especially in the setting of short bowel syndrome, that an MCT fat is better tolerated, better absorbed. ↗
▶ Ep 5 · 7:57
clinical Long-chain fat is the preferred fat module rather than MCT fat, especially in the setting of short bowel syndrome. ↗
▶ Ep 5 · 8:07
quote But I would argue that uh long chain fat is the preferred module rather than MCT. ↗
▶ Ep 5 · 8:15
clinical Long-chain fat is a much stronger stimulus for GLP-2 release compared to MCT, which is important when trying to drive intestinal adaptation. ↗
▶ Ep 5 · 8:15
quote Long chain fat is a much stronger stimulus for GLP-2 release, and that's what we want when we're trying to drive adaptation. ↗
▶ Ep 5 · 9:00
opinion Not every child needs to be on SMOF lipids. ↗
▶ Ep 5 · 9:03
clinical For preterm babies, SMOF is not the ideal lipid emulsion but is the best currently available. ↗
▶ Ep 5 · 9:16
clinical SMOF lipids do not have enough arachidonic acid, which is important for brain development. ↗
Paul's statements about Cholestasis 26 statements

Open the Cholestasis collection →

Intestinal Rehabilitation Webinar 2023 - Top 5 Key Takeaways

▶ Ep 7 · 0:49
quote One key thing to, to acknowledge is that young infants, babies, infants, and young children have tremendous gut growth potential. ↗
▶ Ep 7 · 0:49
clinical Young infants, babies, and young children have tremendous gut growth potential, with the gut growing for the first several years of life. ↗
▶ Ep 7 · 0:58
quote The gut grows for the first several years of life. ↗
▶ Ep 7 · 1:02
clinical Residual bowel should be discussed as a percentage of what is normal for a child of that age, not in absolute centimeters. ↗
▶ Ep 7 · 1:17
clinical A term baby will have 160 centimeters of small bowel, and by age 5 years it almost triples to about 425 to 450 centimeters. ↗
▶ Ep 7 · 1:17
quote So, a term baby uh will have 160 centimeters of small bowel, and by the time you're 5 years old, it, it almost triples, about 425 to 450 centimeters. ↗
▶ Ep 7 · 1:51
quote But you can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 7 · 1:51
clinical You can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 7 · 5:08
quote The overarching principle is we want to, we want to deliver adequate nutrition to, to have normal growth. ↗
▶ Ep 7 · 5:08
clinical The overarching principle is to deliver adequate nutrition to have normal growth within normal parameters, ideally enterally. ↗
▶ Ep 7 · 5:28
clinical As much as possible, the goal is to establish normal feeding behavior, recognizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 7 · 5:28
quote The other guiding principle is, as much as possible, we'd like to try to establish normal feeding behavior. ↗
▶ Ep 7 · 5:34
quote Realizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 7 · 5:52
clinical If a patient needs tube support from the beginning, bolus feeding should be tried rather than defaulting to continuous feeding. ↗
▶ Ep 7 · 6:15
clinical If the child fails a gastric approach (both bolus and continuous), the strategy is to feed beyond the stomach and decompress the stomach through an NG tube. ↗
▶ Ep 7 · 6:42
clinical Breast milk is the formula of choice, not only for its nutritional benefits but for all the other beneficial components within breast milk. ↗
▶ Ep 7 · 6:50
quote Breast milk, not only for its nutritional uh benefits, obviously, but, uh, all the other goodies that are within the breast milk. ↗
▶ Ep 7 · 7:25
quote So let's talk about the protein module first. ↗
▶ Ep 7 · 7:57
clinical Long-chain fat is the preferred fat module rather than MCT fat, especially in the setting of short bowel syndrome. ↗
▶ Ep 7 · 7:57
quote There's this feeling out there that especially in the setting of short bowel syndrome, that an MCT fat is better tolerated, better absorbed. ↗
▶ Ep 7 · 8:07
quote But I would argue that uh long chain fat is the preferred module rather than MCT. ↗
▶ Ep 7 · 8:15
clinical Long-chain fat is a much stronger stimulus for GLP-2 release compared to MCT, which is important when trying to drive intestinal adaptation. ↗
▶ Ep 7 · 8:15
quote Long chain fat is a much stronger stimulus for GLP-2 release, and that's what we want when we're trying to drive adaptation. ↗
▶ Ep 7 · 9:00
opinion Not every child needs to be on SMOF lipids. ↗
▶ Ep 7 · 9:03
clinical For preterm babies, SMOF is not the ideal lipid emulsion but is the best currently available. ↗
▶ Ep 7 · 9:16
clinical SMOF lipids do not have enough arachidonic acid, which is important for brain development. ↗
Paul's statements about Intestinal Failure 26 statements

Open the Intestinal Failure collection →

Intestinal Rehabilitation Webinar 2023 - Top 5 Key Takeaways

▶ Ep 25 · 0:49
clinical Young infants, babies, and young children have tremendous gut growth potential, with the gut growing for the first several years of life. ↗
▶ Ep 25 · 0:49
quote One key thing to, to acknowledge is that young infants, babies, infants, and young children have tremendous gut growth potential. ↗
▶ Ep 25 · 0:58
quote The gut grows for the first several years of life. ↗
▶ Ep 25 · 1:02
clinical Residual bowel should be discussed as a percentage of what is normal for a child of that age, not in absolute centimeters. ↗
▶ Ep 25 · 1:17
clinical A term baby will have 160 centimeters of small bowel, and by age 5 years it almost triples to about 425 to 450 centimeters. ↗
▶ Ep 25 · 1:17
quote So, a term baby uh will have 160 centimeters of small bowel, and by the time you're 5 years old, it, it almost triples, about 425 to 450 centimeters. ↗
▶ Ep 25 · 1:51
quote But you can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 25 · 1:51
clinical You can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 25 · 5:08
quote The overarching principle is we want to, we want to deliver adequate nutrition to, to have normal growth. ↗
▶ Ep 25 · 5:08
clinical The overarching principle is to deliver adequate nutrition to have normal growth within normal parameters, ideally enterally. ↗
▶ Ep 25 · 5:28
quote The other guiding principle is, as much as possible, we'd like to try to establish normal feeding behavior. ↗
▶ Ep 25 · 5:28
clinical As much as possible, the goal is to establish normal feeding behavior, recognizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 25 · 5:34
quote Realizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 25 · 5:52
clinical If a patient needs tube support from the beginning, bolus feeding should be tried rather than defaulting to continuous feeding. ↗
▶ Ep 25 · 6:15
clinical If the child fails a gastric approach (both bolus and continuous), the strategy is to feed beyond the stomach and decompress the stomach through an NG tube. ↗
▶ Ep 25 · 6:42
clinical Breast milk is the formula of choice, not only for its nutritional benefits but for all the other beneficial components within breast milk. ↗
▶ Ep 25 · 6:50
quote Breast milk, not only for its nutritional uh benefits, obviously, but, uh, all the other goodies that are within the breast milk. ↗
▶ Ep 25 · 7:25
quote So let's talk about the protein module first. ↗
▶ Ep 25 · 7:57
clinical Long-chain fat is the preferred fat module rather than MCT fat, especially in the setting of short bowel syndrome. ↗
▶ Ep 25 · 7:57
quote There's this feeling out there that especially in the setting of short bowel syndrome, that an MCT fat is better tolerated, better absorbed. ↗
▶ Ep 25 · 8:07
quote But I would argue that uh long chain fat is the preferred module rather than MCT. ↗
▶ Ep 25 · 8:15
quote Long chain fat is a much stronger stimulus for GLP-2 release, and that's what we want when we're trying to drive adaptation. ↗
▶ Ep 25 · 8:15
clinical Long-chain fat is a much stronger stimulus for GLP-2 release compared to MCT, which is important when trying to drive intestinal adaptation. ↗
▶ Ep 25 · 9:00
opinion Not every child needs to be on SMOF lipids. ↗
▶ Ep 25 · 9:03
clinical For preterm babies, SMOF is not the ideal lipid emulsion but is the best currently available. ↗
▶ Ep 25 · 9:16
clinical SMOF lipids do not have enough arachidonic acid, which is important for brain development. ↗
Paul's statements about Intestinal Rehab 26 statements

Open the Intestinal Rehab collection →

Intestinal Rehabilitation Webinar 2023 - Top 5 Key Takeaways

▶ Ep 83 · 0:49
clinical Young infants, babies, and young children have tremendous gut growth potential, with the gut growing for the first several years of life. ↗
▶ Ep 83 · 0:49
quote One key thing to, to acknowledge is that young infants, babies, infants, and young children have tremendous gut growth potential. ↗
▶ Ep 83 · 0:58
quote The gut grows for the first several years of life. ↗
▶ Ep 83 · 1:02
clinical Residual bowel should be discussed as a percentage of what is normal for a child of that age, not in absolute centimeters. ↗
▶ Ep 83 · 1:17
clinical A term baby will have 160 centimeters of small bowel, and by age 5 years it almost triples to about 425 to 450 centimeters. ↗
▶ Ep 83 · 1:17
quote So, a term baby uh will have 160 centimeters of small bowel, and by the time you're 5 years old, it, it almost triples, about 425 to 450 centimeters. ↗
▶ Ep 83 · 1:51
quote But you can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 83 · 1:51
clinical You can have as low as 10% expected gut length and still achieve enteral autonomy if you have the majority of your colon in continuity. ↗
▶ Ep 83 · 5:08
clinical The overarching principle is to deliver adequate nutrition to have normal growth within normal parameters, ideally enterally. ↗
▶ Ep 83 · 5:08
quote The overarching principle is we want to, we want to deliver adequate nutrition to, to have normal growth. ↗
▶ Ep 83 · 5:28
clinical As much as possible, the goal is to establish normal feeding behavior, recognizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 83 · 5:28
quote The other guiding principle is, as much as possible, we'd like to try to establish normal feeding behavior. ↗
▶ Ep 83 · 5:34
quote Realizing that enteral nutrition is more than just nutrition. ↗
▶ Ep 83 · 5:52
clinical If a patient needs tube support from the beginning, bolus feeding should be tried rather than defaulting to continuous feeding. ↗
▶ Ep 83 · 6:15
clinical If the child fails a gastric approach (both bolus and continuous), the strategy is to feed beyond the stomach and decompress the stomach through an NG tube. ↗
▶ Ep 83 · 6:42
clinical Breast milk is the formula of choice, not only for its nutritional benefits but for all the other beneficial components within breast milk. ↗
▶ Ep 83 · 6:50
quote Breast milk, not only for its nutritional uh benefits, obviously, but, uh, all the other goodies that are within the breast milk. ↗
▶ Ep 83 · 7:25
quote So let's talk about the protein module first. ↗
▶ Ep 83 · 7:57
clinical Long-chain fat is the preferred fat module rather than MCT fat, especially in the setting of short bowel syndrome. ↗
▶ Ep 83 · 7:57
quote There's this feeling out there that especially in the setting of short bowel syndrome, that an MCT fat is better tolerated, better absorbed. ↗
▶ Ep 83 · 8:07
quote But I would argue that uh long chain fat is the preferred module rather than MCT. ↗
▶ Ep 83 · 8:15
clinical Long-chain fat is a much stronger stimulus for GLP-2 release compared to MCT, which is important when trying to drive intestinal adaptation. ↗
▶ Ep 83 · 8:15
quote Long chain fat is a much stronger stimulus for GLP-2 release, and that's what we want when we're trying to drive adaptation. ↗
▶ Ep 83 · 9:00
opinion Not every child needs to be on SMOF lipids. ↗
▶ Ep 83 · 9:03
clinical For preterm babies, SMOF is not the ideal lipid emulsion but is the best currently available. ↗
▶ Ep 83 · 9:16
clinical SMOF lipids do not have enough arachidonic acid, which is important for brain development. ↗